Manalo, Marmie Jane A.
HRN: 12-40-88 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/02/2022
06/09/2022
IV
550mg
Q6
AGN
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes